These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 5804989)

  • 21. [The effect of Halidor on serum lipid fractions in patients with coronary disease and cerebrovascular sclerosis].
    Krámer M; Keller L; Molnár G
    Orv Hetil; 1968 May; 109(21):Suppl:42-3. PubMed ID: 5720723
    [No Abstract]   [Full Text] [Related]  

  • 22. Importance of serum lipids in relation to age, overweight and ischaemic heart disease.
    Soukupová K; Fabián F; Heyrovský A; Reinis Z; Stuchlíková E; Sindelárová I
    Acta Univ Carol Med (Praha); 1969; 15(7):633-40. PubMed ID: 5372271
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical risk factors in coronary disease. The Framingham study].
    Castelli WP
    Wien Med Wochenschr; 1982; 132 Spec No 2():I-IX. PubMed ID: 7168181
    [No Abstract]   [Full Text] [Related]  

  • 24. Role of blood cholesterol in atherosclerosis and coronary heart disease.
    Sherwin R; Lewis C; Russell RP
    Md Med J; 1986 Apr; 35(4):248-50. PubMed ID: 3713460
    [No Abstract]   [Full Text] [Related]  

  • 25. [Thyroid hyperfunction in coronary atherosclerosis].
    Ionescu A; Sneer A; Marcu C; Priboi R
    Stud Cercet Endocrinol; 1971; 22(2):147-58. PubMed ID: 5566236
    [No Abstract]   [Full Text] [Related]  

  • 26. Study of some of the factors in the epidemiology of coronary heart disease in Delhi area.
    Chattopadhaya ML; Mittal MM; Bhatt V; Bhargava SP; Sharma ML
    J Indian Med Assoc; 1969 Apr; 52(7):309-15. PubMed ID: 5801859
    [No Abstract]   [Full Text] [Related]  

  • 27. [Blood lipid levels as indicators of risk in the epidemiology of ischaemic heart disease (author's transl)].
    Pokorný J; Jezková Z
    Sb Lek; 1974 Jan; 76(1):1-7. PubMed ID: 4842894
    [No Abstract]   [Full Text] [Related]  

  • 28. [Why the cardiologists should be interested in lipids?].
    López-Sendón JL; Rubio R; López de Sá E; Delcán JL
    Rev Esp Cardiol; 1995; 48 Suppl 2():23-32. PubMed ID: 7569272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Epidemiologic aspects of ischemic heart disease, arterial hypertension and atherogenic changes in the blood lipid composition of men and women in Leningrad aged 20 to 69].
    Lipovetskiĭ BM; Shestov DB; Plavinskaia SI; Konstantinov VO; Il'ina GN
    Ter Arkh; 1984; 56(4):44-8. PubMed ID: 6233745
    [No Abstract]   [Full Text] [Related]  

  • 30. [Is treatment of metabolic factors a valid method in the control of arteriosclerosis and coronary disease?].
    Avogaro P
    Clin Ter; 1984 Oct; 111(1):15-9. PubMed ID: 6238776
    [No Abstract]   [Full Text] [Related]  

  • 31. Diet and coronary heart disease.
    Stamler J
    Biometrics; 1982 Mar; 38 Suppl():95-118. PubMed ID: 7046825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Framingham Heart Study shows no increases in coronary heart disease rates from cholesterol values of 205 to 264 mg%.
    Seltzer CC
    G Ital Cardiol; 1991 Jun; 21(6):683. PubMed ID: 1743450
    [No Abstract]   [Full Text] [Related]  

  • 33. Altered serum lipid profile after systemic infection in children: risk factor for CHD?
    Pesonen E; Rapola J; Viikari J; Turtinen J; Akerblom HK
    Eur Heart J; 1993 Dec; 14 Suppl K():7-11. PubMed ID: 8131793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The fatty acid composition of serum total lipids and lipid fractions in coronary heart disease and cerebral atherosclerosis.
    Abdel Hay A; Kramer M; Keller L; Retsagi G
    J Egypt Med Assoc; 1970; 53(5):309-20. PubMed ID: 5506287
    [No Abstract]   [Full Text] [Related]  

  • 35. Choice and use of blood lipid tests. An epidemiologic perspective.
    Hulley SB; Lo B
    Arch Intern Med; 1983 Apr; 143(4):667-73. PubMed ID: 6340621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. State of the art coronary heart disease risk estimations based on the Framingham heart study.
    Reissigová J; Tomecková M
    Cent Eur J Public Health; 2005 Dec; 13(4):180-6. PubMed ID: 16419382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of the complex method of Il'k, Dodik and Iovanovich for diagnosis of humoral lipid disorders in coronary atherosclerosis].
    Fomina LF; Sulava SG; Sulava PV
    Ter Arkh; 1968 Jun; 40(6):61-3. PubMed ID: 5739211
    [No Abstract]   [Full Text] [Related]  

  • 38. [Abnormal lipid metabolism and coronary insufficiency].
    Murakami M; Sekimoto H; Tanaka I; Seo M; Takegoshi T
    Saishin Igaku; 1970 Jan; 25(1):101-9. PubMed ID: 5450347
    [No Abstract]   [Full Text] [Related]  

  • 39. Serum lipid screening to identify high-risk individuals for coronary death. The results of the Lipid Research Clinics prevalence cohort.
    Grover SA; Palmer CS; Coupal L
    Arch Intern Med; 1994 Mar; 154(6):679-84. PubMed ID: 8129502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [On the nutritional problems of patients with ischemic heart disease].
    Válek J; Brodan V; Pechar J; Vavrinková H; Marecková O
    Cesk Gastroenterol Vyz; 1968 Oct; 22(7):477-85. PubMed ID: 5704001
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.